The synthesis of AChE inhibitors presents an efficient approach to diagnose the mental symptoms of AD (Alzheimer disorder) and other promising therapeutic applications in the management of ataxia, senile dementia, and Parkinson's disease [49]. Here, ACHE is linked to dementia.